| 000 | 01247 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250513231919.0 | ||
| 264 | 0 | _c20010405 | |
| 008 | 200104s 0 0 eng d | ||
| 022 | _a0923-7534 | ||
| 024 | 7 |
_a10.1023/a:1008325114144 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAndrès, E | |
| 245 | 0 | 0 |
_aInterferon-alpha as first-line therapy for treatment of multicentric Castleman's disease. _h[electronic resource] |
| 260 |
_bAnnals of oncology : official journal of the European Society for Medical Oncology _cDec 2000 |
||
| 300 |
_a1613-4 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 |
_aCastleman Disease _xdrug therapy |
| 650 | 0 | 4 | _aDown-Regulation |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunologic Factors _xadministration & dosage |
| 650 | 0 | 4 | _aInjections, Subcutaneous |
| 650 | 0 | 4 |
_aInterferon-alpha _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aReceptors, Interleukin-6 _xdrug effects |
| 700 | 1 | _aMaloisel, F | |
| 773 | 0 |
_tAnnals of oncology : official journal of the European Society for Medical Oncology _gvol. 11 _gno. 12 _gp. 1613-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1023/a:1008325114144 _zAvailable from publisher's website |
| 999 |
_c11143517 _d11143517 |
||